President Trump’s pause on aid, and the gutting of the primary aid agency, could jeopardize the health of more than 20 ...

King, like hundreds of thousands of other Americans, takes PrEP – preexposure prophylaxis – daily and by doing so, reduces his risk of contracting HIV through sex by 99%. The club DJ and event ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

The Director-General of the National Agency for the Control of AIDS, Dr Temitope Ilori, has said plans are ongoing to support the domestic production of HIV commodities such as test kits and ...

A series of orders from the Trump administration have the potential to disrupt the delivery of life-saving medications to HIV ...

She said domestic production of HIV commodities such as test kits and anti-retroviral drugs was part of measures the ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...

Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, give new options for shorter, personalized treatment ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

With Israel‘s war with Hamas in Gaza remaining ongoing and a ceasefire talks only just beginning, access to life-saving HIV medications in Gaza has all but disappeared. An investigative report ...

Gilead Sciences Inc. and the federal government settled a patent-infringement case in which the US sought $1 billion from the bioscience giant for allegedly using joint research to develop an ...

(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware ...